Jump to search

May 2016arrow

De Vere White to step down as long-time UC Davis Comprehensive Cancer Center director

May 31, 2016

Ralph de Vere White, a beloved urologist and acclaimed researcher who led the UC Davis Comprehensive Cancer to designation by the National Cancer Institute (NCI), steps down as its long-time director on June 29.

National Cancer Institute re-designates the cancer center

May 17, 2016

The National Cancer Institute (NCI) has re-designated the UC Davis Comprehensive Cancer Center “comprehensive,” meaning that it meets stringent criteria in the areas of laboratory, clinical and population-based research, professional and public education and in the dissemination of clinical and public advances to the communities it serves.

April 2016arrow

Stem cell research reveals myelin repair capacity

April 28, 2016

In a study published today in Cell Reports, Wenbin Deng and his colleagues present data showing that immature astroglial transplants, derived from human-induced pluripotent stem cells (iPSCs), are highly protective against white matter brain injury — which can occur from lack of oxygen following a stroke or in childbirth — and can improve spatial learning and memory function in mouse models.

New study tests stem cells as a treatment for degenerative disc disease

April 25, 2016

As part of a new multicenter clinical trial, UC Davis Health System researchers will test whether a novel stem cell treatment can reduce the pain and mobility issues caused by degenerative disc disease.

March 2016arrow

State stem cell agency approves research funding for UC Davis scientists

March 21, 2016

Two new UC Davis research efforts, one aimed at addressing fatal early childhood conditions known as Tay-Sachs and Sandhoff disease, the other designed to develop an immunotherapy that would eradicate solid tumor cancer stem cells and create sustained anti-tumor effects, have been approved for funding by the California Institute for Regenerative Medicine (CIRM).

Human stem cells target Huntington's disease

March 15, 2016

In a promising finding for research into Huntington’s disease (HD) — the devastating inherited neurodegenerative disorder — a team of UC Davis investigators has identified for the first time a way to use human mesenchymal stem cells (MSCs) to deliver the key brain protein growth factor that is dramatically diminished by Huntington’s disease.

February 2016arrow

New study tests stem cells as a treatment for degenerative disc disease

February 10, 2016

As part of a new multicenter clinical trial, UC Davis Health System researchers will test whether a novel stem cell treatment can reduce the pain and mobility issues caused by degenerative disc disease.

January 2016arrow

Researchers decipher stem cell messages in blood vessel formation

January 19, 2016

An international collaboration between UC Davis and Swedish scientists has resulted in the first comprehensive characterization of a recently discovered cell-to-cell communication system used by stem cells.

December 2015arrow

Two UC Davis experts among speakers at World Stem Cell Summit

December 9, 2015

Two UC Davis Health System scientists are among the featured speakers at the upcoming World Stem Cell Summit and Regenerative Medicine conference that starts Dec. 10 in Atlanta.

September 2015arrow

Cancer Center joins collaborative molecular oncology intiative

September 15, 2015

The UC Davis Comprehensive Cancer Center has joined a unique new collaboration to accelerate the development of precision cancer treatment through the collection and sharing of genomics data

August 2015arrow

New York Blood Center partners with UC Davis Health System to produce more viable stem cell therapies

August 20, 2015

New York Blood Center (NYBC) today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.

UC Davis team finds early inflammatory response paralyzes T cells

August 18, 2015

In a discovery that is likely to rewrite immunology text books, researchers at UC Davis have found that early exposure to inflammatory cytokines, such as interleukin 2, can “paralyze” CD4 T cells, immune components that help orchestrate the body’s response to pathogens and other invaders.

July 2015arrow

UC Davis awards new technology grants to health system researchers

July 29, 2015

UC Davis Health System investigators are among the winners of this year’s Science Translation and Innovative Research (STAIR) grants for research projects with commercial feasibility.

UC Davis researchers awarded grant for HIV clinical trial using stem cells

July 23, 2015

The state stem cell agency, the California Institute for Regenerative Medicine (CIRM), today approved funding a UC Davis Health System research team to conduct a clinical trial using bioengineered stem cells to treat HIV patients suffering from lymphoma, one of the deadly conditions associated with the disease.

UC Davis researcher receives grant to study psoriatic arthritis

July 20, 2015

Iannis Adamopoulos, a researcher dedicated to studying diseases of the immune and skeletal systems, has received a $200,000 grant from the National Psoriasis Foundation to improve treatments for psoriatic arthritis.